Oral health professionals located in areas with “moderate to substantial community transmission” of the novel coronavirus should wear N95 masks or respirators when performing procedures that increase the risk of transmission, such as those…

The United States Department of Health and Human Services announced it has secured 300 million doses of an experimental vaccine created by AstraZeneca in partnership with Oxford University as part of Operation Warp Speed. The influx of cash…

A $4 million gift from the W. M. Keck Foundation will help scientists at the Keck School of Medicine of USC explore how the new coronavirus is transmitted, develop treatments, and work with public health officials to curtail its spread.

The United States Centers for Disease Control and Prevention (CDC) released updated guidelines for dental practices on May 19. The new guidance focuses on providing the most necessary dental services first and limiting the risk of an…

A team at New York University (NYU) is working to better understand the cellular and molecular mechanisms of how oral cancer cells invade nerves to help researchers identify new targets for treating patients with oral cancer and associated…

Researchers at the Finnish Center for Artificial Intelligence, Tampere University Hospital, Planmeca Oy, and the Alan Turing Institute are using artificial intelligence (AI) to accurately identify the location of mandibular canals.

A newly developed mouthguard may help detect the early signs of caries and periodontitis, according to a team of Chinese researchers.

The United States Occupational Safety and Health Administration (OSHA) has released the following tips to help safeguard oral health professionals as they return to practice. Encourage clinicians and staff to stay home if sick…

 The Department of Education (ED) has released $3 billion in funding to states to address the unmet needs of the educational community caused by COVID-19 disruptions

A COVID-19 vaccine—created by Moderna in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID)—seems to initiate an immune response in a Phase 1 trial, giving hope to the possibility of an effective vaccine in…